The following data is part of a premarket notification filed by Kensey Nash Corp. with the FDA for Triactiv System.
| Device ID | K042040 |
| 510k Number | K042040 |
| Device Name: | TRIACTIV SYSTEM |
| Classification | Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection |
| Applicant | KENSEY NASH CORP. 55 EAST UWCHLAN AVE. MARSH CREEK CORP. CENTER Exton, PA 19341 -1247 |
| Contact | Robin M Fatzinger |
| Correspondent | Robin M Fatzinger KENSEY NASH CORP. 55 EAST UWCHLAN AVE. MARSH CREEK CORP. CENTER Exton, PA 19341 -1247 |
| Product Code | NFA |
| CFR Regulation Number | 870.1250 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2004-07-29 |
| Decision Date | 2005-03-23 |
| Summary: | summary |